| Literature DB >> 34335164 |
Yujie Wu1,2, Donghang Zhang1,2, Jin Liu1,2, Yaoxin Yang1,2, Mengchan Ou1,2, Bin Liu2, Cheng Zhou1,2.
Abstract
Ethanol can induce acute stimulant responses in animals and human beings. Moreover, repeated exposure to ethanol may produce increased sensitivity to its acute locomotor stimulant actions, a process referred to as locomotor sensitization. The molecular mechanism of the development of acute stimulant responses and locomotor sensitization by ethanol is not fully understood. Sodium leak channel (NALCN) is widely expressed in central nervous system and controls the basal excitability of neurons. The present study aims to determine whether NALCN is implicated in the ethanol-induced acute responses and locomotor sensitization in mice. Here, our results showed that ethanol caused acute stimulant responses in DBA/2 mice. Locomotor sensitization was successfully induced following the sensitization procedure. Accordingly, the expression levels of NALCN mRNA and protein in the nucleus accumbens (NAc) were markedly increased in the sensitization mice compared to the control mice. Knockdown the expression levels of NALCN in the NAc alleviated both the ethanol-induced acute responses and locomotor sensitization. Our findings indicate that upregulation of NALCN expression in the NAc contributes to the ethanol-induced acute stimulant responses and locomotor sensitization in DBA/2 mice.Entities:
Keywords: NALCN; acute responses; ethanol; locomotor sensitization; nucleus accumbens
Year: 2021 PMID: 34335164 PMCID: PMC8316816 DOI: 10.3389/fnins.2021.687470
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
The procedure of ethanol induction.
| Groups | Habituation | Baseline | Acute ethanol | Daily treatments (induction) | Sensitization (verification) |
| Time points | 2 days | Day 0 | Day 1 | Days 2–10 | Day 11 |
| NS group | NS | NS | NS | NS | NS |
| Ethanol group | NS | NS | Ethanol (2 g/kg) | Ethanol (2 g/kg) | Ethanol (2 g/kg) |
FIGURE 1Expression of NALCN increases after ethanol-induced locomotor sensitization. (A) Ethanol injection induced acute stimulant locomotion compared to NS. Repeated treatment with ethanol induced locomotor sensitization (n = 10; t = 5.71, df = 18, ***P < 0.001 compared with baseline; Fsensitization(1,9) = 740.45, ***P < 0.001 compared with NS group; t = 2.22, df = 18, #P < 0.05 compared with day 1 in the ethanol group; t = 3.20, df = 18, ##P < 0.01 compared with day 1 in the ethanol group; t = 3.00, df = 18, &&P < 0.01 compared with the ethanol group). (B) Representative images of c-Fos staining (left) showed that c-Fos expression was greater in the NAc of sensitization mice after ethanol injection, compared to the control mice (right, n = 5, t = 5.62, df = 8, ***P < 0.001). (C) Expression of NALCN mRNA in the NAc was significantly increased after repeated exposure to ethanol (n = 6, t = 3.32, df=10, **P < 0.01). (D) Expression of NALCN protein in the NAc was significantly increased after repeated exposure to ethanol (n = 7−9, t = 6.19, df=14, ***P < 0.001). (E) Representative images of NALCN staining (left) showed that NALCN expression was greater in the NAc of sensitization mice after ethanol injection, compared to the control mice (right, n = 5, t = 5.61, df = 8, ***P < 0.001). Data are present as mean ± SD. Panel (A) was compared by two-way ANOVA; (B) right, (C,D) right, and (E) right were compared by unpaired two-tailed student’s t-test. The results contained three replicates across cohorts of mice.
FIGURE 2Knockdown the NALCN expression alleviated the ethanol induced acute stimulant responses and locomotor sensitization. (A) Representative images of AAV-GFP expression in NAc 4 weeks after injection. (B) Knockdown the NALCN expression in NAc by AAV-NALCN-shRNA significantly inhibited the ethanol induced acute stimulant responses and locomotor sensitization [n = 10, t = 6.69, df = 18, ***P < 0.001 compared with baseline; t = 2.31, df = 18, *P < 0.05 compared with day 1 in the AAV-scrambled-shRNA + ethanol group; t = 2.31, df = 18, **P < 0.05 compared with day 1 in the AAV-scrambled-shRNA + ethanol group; t = 2.45, df = 18, #P < 0.05 compared with the AAV-scrambled-shRNA + NS group; t = 2.33, df = 18, ##P < 0.05 compared with the AAV-scrambled-shRNA + NS group; &P < 0.05 for AAV-NALCN-shRNA+NS group (Finteraction(9,81) = 2.47) or AAV-scrambled-shRNA+NS group (Finteraction(9,81) = 2.20) compared with the AAV-scrambled-shRNA+ethanol group]. (C,D) Expression levels of NALCN mRNA was significantly decreased in NAc by AAV-NALCN-shRNA [(C): n = 6; t = 8.63, df = 10, ***P < 0.001; (D): n = 5–11; t = 11.09, df = 13, ***P < 0.001]. (E,F) Expression levels of NALCN protein was significantly decreased in NAc by AAV-NALCN-shRNA [n = 3–7, (E): t = 9.77, df = 7, ***P < 0.001; (F): t = 8.39, df = 8, ***P < 0.001]. Data are present as mean ± SD. Panel (A) was compared by two-way ANOVA; (C,D) right and (E) right were compared by unpaired two-tailed student’s t-test. The results contained three replicates across cohorts of mice.